These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 21204952)
41. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp. McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305 [TBL] [Abstract][Full Text] [Related]
42. Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner. Matsuzawa T; Fukui A; Kashimoto T; Nagao K; Oka K; Miyake M; Horiguchi Y J Biol Chem; 2004 Jan; 279(4):2866-72. PubMed ID: 14597616 [TBL] [Abstract][Full Text] [Related]
43. Pleiotropic role of Rac in mast cell activation revealed by a cell permeable Bordetella dermonecrotic fusion toxin. Stratmann H; Schwan C; Orth JH; Schmidt G; Aktories K Cell Signal; 2010 Jul; 22(7):1124-31. PubMed ID: 20211724 [TBL] [Abstract][Full Text] [Related]
44. Bordetella dermonecrotic toxin exerting toxicity through activation of the small GTPase Rho. Fukui A; Horiguchi Y J Biochem; 2004 Oct; 136(4):415-9. PubMed ID: 15625308 [TBL] [Abstract][Full Text] [Related]
45. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases. Horiguchi Y Toxicon; 2001 Nov; 39(11):1619-27. PubMed ID: 11595625 [TBL] [Abstract][Full Text] [Related]